In breast cancer, CAFs have been shown to act in a paracrine manner through secretion of inflammatory modulators such as IL-6, inducing Notch activation in cancer cells and thus promoting the stem cell phenotype and resistance [136,137]. The gene discussed is IL6; the disease is breast carcinoma.